Erythropoietin protects pancreatic β-cell line NIT-1 cells against cytokine-induced apoptosis via phosphatidylinositol 3-kinase/Akt signaling

Endocrine Research

Volumn 36, Issue 1, 2011, Pages 25-34

  Shuai, Hongxia ^a   Zhang, Ji ^a   Zhang, Jinghui ^a   Xie, Junhui ^a   Zhang, Muxun ^a   Yu, Yikai ^a   Zhang, Liming ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Apoptosis; Cytokine; Erythropoietin; Erythropoietin receptor; Phosphatidylinositol 3 kinase

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CYTOKINE; ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; GAMMA INTERFERON; INSULIN; INTERLEUKIN 1BETA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BCL 2; PROTEIN KINASE B; RECOMBINANT ERYTHROPOIETIN; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; INSULIN RELEASE; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL LINE; CYTOKINES; ENZYME ACTIVATION; ERYTHROPOIETIN; ERYTHROPOIETIN, RECOMBINANT; HUMANS; INSULIN; INSULIN-SECRETING CELLS; MICE; PHOSPHATIDYLINOSITOL 3-KINASE; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RECEPTORS, ERYTHROPOIETIN; SIGNAL TRANSDUCTION;

EID: 78651434051     PISSN: 07435800     EISSN: 15324206     Source Type: Journal    
DOI: 10.3109/07435800.2010.534753     Document Type: Article

References (42)

1. Kharroubi I, Ladrière L, Cardozo AK, Dogusan Z, Cnop M, Eizirik DL. Free fatty acids and cytokines induce pancreatic ǎ-cell apoptosis by different mechanisms: role of nuclear factor-ěB and endoplasmic reticulum stress. Endocrinology 2004;145(11):5087-5096.
2. Melloul D. Role of NF-ěB in ǎ-cell death. Biochem Soc Trans 2008;36(Pt. 3):334-339.
3. Roche E, Maestre I, Martín F, et al. Nutrient toxicity in pancreatic ǎ-cell dysfunction. J Physiol Biochem 2000;56(2):119-128.
4. Wu H, Liu X, Jaenisch R, Lodish HF. Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell 1995;83(1):59-67.
5. Kapur R, Zhang L. A novel mechanism of cooperation between c-Kit and erythropoietin receptor. Stem cell factor induces the expression of Stat5 and erythropoietin receptor, resulting in efficient proliferation and survival by erythropoietin. J Biol Chem 2001;276(2):1099-1106.
6. Witthuhn BA, Quelle FW, Silvennoinen O, et al. JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin. Cell 1993;74(2):227-236.
7. Ihle JN. The Janus kinase family and signaling through members of the cytokine receptor superfamily. Proc Soc Exp Biol Med 1994;206(3):268-272.
8. Miura O, Nakamura N, Quelle FW, Witthuhn BA, Ihle JN, Aoki N. Erythropoietin induces association of the JAK2 protein tyrosine kinase with the erythropoietin receptor in vivo. Blood 1994; 84(5):1501-1507.
9. Miura O, Miura Y, Nakamura N, et al. Induction of tyrosine phosphorylation of Vav and expression of Pim-1 correlates with Jak2-mediated growth signaling from the erythropoietin receptor. Blood 1994;84(12):4135-4141.
10. Bao H, Jacobs-Helber SM, Lawson AE, Penta K, Wickrema A, Sawyer ST. Protein kinase B (c-Akt), phosphatidylinositol 3-kinase, and STAT5 are activated by erythropoietin (EPO) in HCD57 erythroid cells but are constitutively active in an EPO-independent, apoptosis-resistant subclone (HCD57-SREI cells). Blood. 1999;93(11):3757-3773.
11. Haseyama Y, Sawada K, Oda A, et al. Phosphatidylinositol 3-kinase is involved in the protection of primary cultured human erythroid precursor cells from apoptosis. Blood 1999;94(5):1568-1577.
12. Uddin S, Kottegoda S, Stigger D, Platanias LC, Wickrema A. Activation of the Akt/FKHRL1 pathway mediates the antiapoptotic effects of erythropoietin in primary human erythroid progenitors. Biochem Biophys Res Commun 2000;275(1):16-19.
13. Silva M, Benito A, Sanz C, et al. Erythropoietin can induce the expression of bcl-x(L) through Stat5 in erythropoietin-dependent progenitor cell lines. J Biol Chem 1999;274(32):22165-22169.
14. Socolovsky M, Nam H, Fleming MD, Haase VH, Brugnara C, Lodish HF. Ineffective erythropoiesis in Stat5a(?/?)5b(?/?) mice due to decreased survival of early erythroblasts. Blood 2001;98(12):3261-3273.
15. Socolovsky M, Fallon AE, Wang S, Brugnara C, Lodish HF. Fetal anemia and apoptosis of red cell progenitors in Stat5a?/?5b?/? mice: a direct role for Stat5 in Bcl-X(L) induction. Cell 1999; 98(2):181-191.
16. Mori M, Uchida M, Watanabe T, et al. Activation of extracellular signal-regulated kinases ERK1 and ERK2 induces Bcl-xL up-regulation via inhibition of caspase activities in erythropoietin signaling. J Cell Physiol 2003;195(2):290-297.
17. Farrell F, Lee A. The erythropoietin receptor and its expression in tumor cells and other tissues. Oncologist 2004;9(Suppl. 5):18-30.
18. Nagai A, Nakagawa E, Choi HB, Hatori K, Kobayashi S, Kim SU. Erythropoietin and erythropoietin receptors in human CNS neurons, astrocytes, microglia, and oligodendrocytes grown in culture. J Neuropathol Exp Neurol 2001;60(4):386-392.
19. Anagnostou A, Lee ES, Kessimian N, Levinson R, Steiner M. Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells. Proc Natl Acad Sci USA 1990;87(15):5978-5982.
20. Anagnostou A, Liu Z, Steiner M, et al. Erythropoietin receptor mRNA expression in human endothelial cells. Proc Natl Acad Sci USA 1994;91(9):3974-3978. (Pubitemid 24139555)
21. Mioni R, Gottardello F, Bordon P, Montini G, Foresta C. Evidence for specific binding and stimulatory effects of recombinant human erythropoietin on isolated adult rat Leydig cells. Acta Endocrinol (Copenh) 1992;127(5):459-465.
22. Ogilvie M, Yu X, Nicolas-Metral V, et al. Erythropoietin stimulates proliferation and interferes with differentiation of myoblasts. J Biol Chem 2000;275(50):39754-39761.
23. Fraser JK, Tan AS, Lin FK, Berridge MV. Expression of specific high-affinity binding sites for erythropoietin on rat and mouse megakaryocytes. Exp Hematol. 1989;17(1):10-16.
24. Burger D, Lei M, Geoghegan-Morphet N, Lu X, Xenocostas A, Feng Q. Erythropoietin protects cardiomyocytes from apoptosis via up-regulation of endothelial nitric oxide synthase. Cardiovasc Res 2006;72(1):51-59.
25. Vairano M, Dello Russo C, Pozzoli G, et al. Erythropoietin exerts anti-apoptotic effects on rat microglial cells in vitro. Eur J Neurosci 2002;16(4):584-592.
26. Yoshimi M, Maeyama T, Yamada M, et al. Recombinant human erythropoietin reduces epithelial cell apoptosis and attenuates bleomycin-induced pneumonitis in mice. Respirology 2008; 13(5):639-645.
27. Vorobiov M, Malki M, Shnaider A, et al. Erythropoietin prevents dialysis fluid-induced apoptosis of mesothelial cells. Perit Dial Int 2008;28(6):648-654.
28. Zhang J, Wu Y, Jin Y, et al. Intravitreal injection of erythropoietin protects both retinal vascular and neuronal cells in early diabetes. Invest Ophthalmol Vis Sci 2008;49(2):732-742.
29. Acs G, Chen M, Xu X, Acs P, Verma A, Koch CJ. Autocrine erythropoietin signaling inhibits hypoxiainduced apoptosis in human breast carcinoma cells. Cancer Lett 2004;214(2):243-251.
30. Um M, Lodish HF. Antiapoptotic effects of erythropoietin in differentiated neuroblastoma SH-SY5Y cells require activation of both the STAT5 and AKT signaling pathways. J Biol Chem 2006;281(9):5648-5656.
31. Jetton TL, Lausier J, LaRock K, et al. Mechanisms of compensatory ǎ-cell growth in insulin-resistant rats: roles of Akt kinase. Diabetes 2005;54(8):2294-2304.
32. Dickson LM, Rhodes CJ. Pancreatic ǎ-cell growth and survival in the onset of type 2 diabetes: a role for protein kinase B in the Akt? Am J Physiol Endocrinol Metab 2004;287(2):E192-E198.
33. Wrede CE, Dickson LM, Lingohr MK, Briaud I, Rhodes CJ. Protein kinase B/Akt prevents fatty acidinduced apoptosis in pancreatic ǎ-cells (INS-1). J Biol Chem 2002;277(51):49676-49684.
34. Vlahos CJ, Matter WF, Hui KY, Brown RF. A specific inhibitor of phosphatidylinosito3-kinase, 2-(4- morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem 1994;269(7):5241-5248.
35. Iwahashi H, Hanafusa T, Eguchi Y, et al. Cytokine-induced apoptotic cell death in a mouse pancreatic ǎ-cell line: inhibition by Bcl-2. Diabetologia 1996;39(5):530-536.
36. Witthuhn BA, Quelle FW, Silvennoinen O, et al. JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin. Cell 1993;74(2):227-236.
37. Ohashi H, Maruyama K, Liu YC, Yoshimura A. Ligand-induced activation of chimeric receptors between the erythropoietin receptor and receptor tyrosine kinases. Proc Natl Acad Sci USA 1994;91(1):158-162.
38. Fatrai S, Elghazi L, Balcazar N, et al. Akt induces ǎ-cell proliferation by regulating cyclin D1, cyclin D2, and p21 levels and cyclin-dependent kinase-4 activity. Diabetes 2006;55(2):318-325.
39. Peshavaria M, Larmie BL, Lausier J, et al. Regulation of pancreatic ǎ-cell regeneration in the normoglycemic 60% partial-pancreatectomy mouse. Diabetes 2006;55(12):3289-3298.
40. Sen P, Mukherjee S, Ray D, Raha S. Involvement of the Akt/PKB signaling pathway with disease processes. Mol Cell Biochem 2003;253(1-2):241-246.
41. Rabinovitch A, Suarez-Pinzon W, Strynadka K, et al. Transfection of human pancreatic islets with an anti-apoptotic gene (bcl-2) protects ǎ-cells from cytokine-induced destruction. Diabetes 1999;48(6):1223-1229.
42. Fenjves ES, Ochoa MS, Gay-Rabinstein C, et al. Adenoviral gene transfer of erythropoietin confers cytoprotection to isolated pancreatic islets. Transplantation 2004;77(1):13-18.